Stay updated on Crenolanib in D842V GIST: Clinical Trial
Sign up to get notified when there's something new on the Crenolanib in D842V GIST: Clinical Trial page.

Latest updates to the Crenolanib in D842V GIST: Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the 403 error page for the study record.SummaryDifference1%

- Check11 days agoChange DetectedThe site revision label in the page footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe study record page is showing a 403 Forbidden message rather than clinical trial information.SummaryDifference0.5%

- Check39 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study content with an access-denied message. This indicates that the record is no longer accessible and the usual study details and navigation are not presented.SummaryDifference16%

- Check60 days agoChange DetectedThe page now includes a 2015 NIH grant/contract entry under Other Study ID Numbers. The page revision has been updated to Revision: v3.6.6, replacing the prior v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Crenolanib in D842V GIST: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib in D842V GIST: Clinical Trial page.